| VCH-916 |
| 5-(1-Cyclohexen-1-yl)-3-[(trans-4-methoxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid potassium salt |
| (CAS 1200133-34-1) |
 |
| Description： |
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
The RNA-dependent RNA polymerase (NS5B) of HCV is one of the attractive validated targets for development of new drugs to block HCV infection. VCH-916 is currently being evaluated for safety/tolerability, pharmacokinetics and anti-viral efficacy in chronically infected HCV patient.
|
| Product No. |
KT00945 |
| Product Name |
VCH-916 |
| Synonyms |
VCH916; VCH 916 |
| Formal Name |
5-(1-Cyclohexen-1-yl)-3-[(trans-4-methoxycyclohexyl)[(trans-4-methylcyclohexyl)carbonyl]amino]-2-thiophenecarboxylic acid potassium salt |
| CAS Number |
1200133-34-1 |
| Molecular Formula |
C26H36NO4S.K |
| Formula Weight |
497.73 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
ABT-333
Anguizole
Artemisinin
Asunaprevir
Balapiravir
Ciluprevir
|
|
